Walleye Capital
TEVA icon

Walleye Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Walleye Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,309
Closed -$76.9K – 5163
2026
Q1 		$69.5K Buy
+2,309
New +$74.3K ﹤0.01% 3800
2025
Q4 		– Sell
-69,150
Closed -$1.7M – 5130
2025
Q3 		$1.4M Sell
69,150
-72,041
-51% -$1.27M 0.01% 1839
2025
Q2 		$2.37M Sell
141,191
-122,066
-46% -$1.97M 0.01% 1383
2025
Q1 		$4.05M Sell
263,257
-745,626
-74% -$13.3M 0.02% 928
2024
Q4 		$22.2M Sell
1,008,883
-94,177
-9% -$1.71M 0.05% 298
2024
Q3 		$19.9M Buy
1,103,060
+949,026
+616% +$16.6M 0.04% 331
2024
Q2 		$2.5M Buy
154,034
+152,639
+10,942% +$2.35M ﹤0.01% 1891
2024
Q1 		$19.7K Sell
1,395
-225,056
-99% -$2.84M ﹤0.01% 4933
2023
Q4 		$2.36M Buy
226,451
+187,581
+483% +$1.75M 0.01% 1664
2023
Q3 		$396K Buy
+38,870
New +$362K ﹤0.01% 2989
2020
Q1 		– Sell
-13,752
Closed -$135K – 1638
2019
Q4 		$135K Sell
13,752
-136,318
-91% -$1.22M 0.01% 1281
2019
Q3 		$1.03M Buy
+150,070
New +$1.15M 0.06% 437
2019
Q2 		– Sell
-16,218
Closed -$196K – 2030
2019
Q1 		$254K Buy
+16,218
New +$286K 0.04% 672

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Walleye Capital's TEVA Position: Q2 2026 in Review

Walleye Capital sold out of Teva Pharmaceuticals (TEVA) in Q2 2026, closing a stake of 2,309 shares — an estimated $76.9K sold.

Walleye Capital first reported a position in TEVA in Q1 2019 and held it in 13 quarters. The position peaked at $22.2M in Q4 2024. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Walleye Capital reported no remaining Teva Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Walleye Capital sold 2,309 Teva Pharmaceuticals shares in Q2 2026, an estimated $76.9K.
  • Walleye Capital first reported a position in Teva Pharmaceuticals in Q1 2019 and held it in 13 quarters.
  • Walleye Capital's Teva Pharmaceuticals position peaked at $22.2M in Q4 2024.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.